Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Optical Tweezers Reveal Limitation of Nanoparticle Mobility in Lung Mucus

By LabMedica International staff writers
Posted on 29 Oct 2012
A study using sophisticated laboratory instruments has provided important insights into the structure of the lung mucus and revealed the cause for limited mobility of nanoparticles within the mucus. More...
The findings have particularly important implications for inhaled-drug development as well as for better understanding of viral lung infection and airway pollution pathologies.

Evidence has been contradictory as to the extent to which nanoparticles can move through the lung mucus and scientists have been unable to explain why some inhaled drug medications do not reach their theoretically predicted target destinations. A European team led by scientists at Saarland University (Saarbruecken, Germany) and the Helmholtz Center for Infection Research (HZI; Saarbruecken, Germany) has now shed light on this dilemma using a novel, highly specialized approach combining cryogenic scanning electron microscopy, magnetic field movement tests, and optical tweezers force assessment tests. The researchers found that nanoparticles are blocked by the unusual gel rod structures that function like bars of a cage.

Claus-Michael Lehr, professor for Biopharmacy and Pharmaceutical Technology at the Saarland University and head of the "Drug Delivery" Department at the Helmholtz Institute for Pharmaceutical Research Saarland, a branch of the HZI, explained that normal gels have a microstructure that resembles a delicate spiderweb made from thin, very fine threads that enclose small pores. When viewed under the microscope, lung mucus, by comparison, looks more like a sponge, with rigid, thick gel rods separating large pores filled with liquid gel. These scaffold proteins are called mucins. There is also high heterogeneity in the size of the voids and pores in mucus. Many previous studies found nanoparticles in the mucus to be highly mobile because the research was done on a nanometer scale, measuring movement inside the individual liquid gel containing pores, not between the pores. The current study has now shown that nanoparticle movement through the mucus mesh is obstructed by the high rigidity of the scaffolding surrounding the pores.

One of the research tools used in the study was a set of optical tweezers operated by Prof. Christian Wagner and his team of experimental physicists at the Saarland University: bundled laser beams used to grab and move the nanoparticles similar to regular pair of tweezers. "We can use the optical tweezers' laser beams to measure the force that is required to move a particle within the gel. This allows us to make conclusions about the medium that the bead is moved through," explained Prof. Wagner. "We were able to pull the bead through the liquid inside the pore at a constant force – just as we would if we were dealing with a normal gel. However, whenever the bead hits the pore's wall, in other words the mucus's gel rods, the laser beam is unable to move it any further."

The study was published before print, online, on October 22, 2012, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:

Saarland University
Helmholtz Centre for Infection Research



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.